2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- -50.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Emergent Health (EMGE)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 43
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 06/01/2026
Company Profile
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. was incorporated in 2006 and is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.
Key Executives
- Marvin Segel
- Gregory McCauley
- James W. Zimbler
Current Ownership Distribution
- Other41.9M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)